Clinical Trial Update: Efficacy and Safety Analyses of Mirtazapine in NSCLC Patients With Depression [Phase 2]

View source ↗

Summary

Phase 2 trial update analyzing the efficacy and safety of mirtazapine in patients with non-small cell lung cancer and depression.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Non-small Cell Lung Cancer

Drugs mentioned

• mirtazapine (mirtazapine)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Carcinoma, Non-Small-Cell Lung, Depression | Phase 2 | Status: UNKNOWN